Enhancing Predictive Value in Immunophenotyping for Cell Therapy Efficacy
Time: 2:30 pm
day: Track B - Immunophenotype Assay (Day One - Afternoon)
Details:
- What are the main obstacles in establishing a direct correlation between immunophenotyping data and therapeutic outcomes in cell therapy?
- How can we develop and implement standardized guidelines for immunophenotyping to ensure consistent and reliable results across different contexts?
- What innovative methodologies or technologies could enhance the assessment of inflammation and immune activity, thereby improving the predictive value of immunophenotyping in therapeutic settings?
